MedTrace Logo

Study to Assess Tolerance of Traces in Peanut/Tree Nut Allergic Children.

NCT03680066 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2023-12-05

No results posted yet for this study

Summary

This protocol will help better define whether patients with peanut and/or tree nut food allergy can tolerate traces in products with precautionary allergen labelling.

Conditions

Interventions

OTHER

Oral food challenge to foods with traces

Subjects will undergo an open food challenge to 3 processed foods labeled with "may contain traces". The following foods (similar for all patients) will be given in one dose in the size of a regular serving: * cookies, max 30 g; * chocolate, max 30 g; * breakfast cereals, max 50 g. Each meal will be administered with a 1 hour observation period in between and at the end.

Sponsors & Collaborators

  • University Hospital, Geneva

    lead OTHER

Principal Investigators

  • Philippe Eigenmann, MD · University Hospitals of Geneva

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2023-11-28
Completion
2023-11-28

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03680066 on ClinicalTrials.gov